This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Investigations

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Routine blood tests are not carried out in primary Raynaud’s phenomenon (1).

A small group of investigations are helpful in patients with a clinical suspicion of secondary Raynaud’s phenomenon:

  • full blood count and ESR
  • presence of anaemia and lymphopenia, may suggest an underlying autoimmune disease;
  • immunology test for antinuclear antibodies (ANA), anti-Ro (SS-A), and anti-La (SS-B) etc
  • examination of nailfold capillaries:
  • capillaroscopy is better since ophthalmoscopy (20× magnification, dermatoscope 10× magnification) can miss capillary changes
  • but the gold standard method is videocapillaroscopy (200× magnification, or a biomicroscope)
  • shows abnormal morphological patterns, e.g. dilatation, haemorrhages, loss of capillaries, angiogenesis etc (1)
  • chest X-ray - in patients with unilateral signs to look for a cervical rib compressing the bronchial and cephalic vascular branches
  • renal and liver function tests
  • TFTs
  • cryoglobulin estimation
  • urinalysis
  • hand X-ray (1,2,3)

Specialist investigations carried out in secondary care include:

  • infrared thermography
  • laser doppler flowmetry
  • portable radiometry
  • digital plethymography (1)

Note:

  • laboratory tests must be used in conjunction with clinical features (1).

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.